Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03373240 · ClinicalTrials.gov registry record · NA
Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03373240 is a NA study that has completed, run by Yale University. The registered enrollment target is 46 participants.
The verdict
NCT03373240, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
We are proposing a small randomized clinical trial in which 100 substance users will complete the existing Psychotherapy Development Center (PDC) pretreatment assessment battery as well as a novel battery of assays to evaluate cognitive-affective functioning. After completing pretreatment assessments, participants will be randomized to either a (1) cognitive remediation program (training tasks) specifically designed to address cognitive-affective dysregulation or (2) control tasks (verbal fluency tasks). Tasks will be completed twice per week for 4 weeks, after which assessment batteries will be repeated. Finally, we will evaluate real-world behavior and the durability of the training via a one-month follow-up, which will include assessment of substance use as well as the cognitive-affective battery.
Interventions
- BEHAVIORAL TAU plus Cognitive Remediation Program
- BEHAVIORAL TAU plus Control Tasks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-01-22 |
| Est. Completion | 2019-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03373240
The ClinicalTrials.gov registry entry for NCT03373240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAU plus Cognitive Remediation Program is the first listed.
NCT03373240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03373240 about?
NCT03373240 is a clinical study titled "Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention". We are proposing a small randomized clinical trial in which 100 substance users will complete the existing Psychotherapy Development Center (PDC) pretreatment assessment battery as well as a novel battery of assays to evaluate cognitive-affective functioning. After completing pretreatment assessment...
What is the current status of trial NCT03373240?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-01-22. Estimated completion is 2019-10-17.
What interventions are being tested in trial NCT03373240?
The interventions under investigation include: TAU plus Cognitive Remediation Program (BEHAVIORAL), TAU plus Control Tasks (BEHAVIORAL).
Who is sponsoring clinical trial NCT03373240?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.